A central concept is to get access to databases named new therapeutic lotions for subsisting drugs with obvious possibilities.
Most researchers agree that 50K+ empowered 20K+ drugs, with clinical evidence, genetic support and regulative traffic passports .
Existing drugs, new indications.
See Database Documentation
Phase II+ data, GWAS hits, phenotypic screens combined.
On top of that, the deduction of multisource information produces confidence scores repurposing with enquiry answers down chief publications and test results.
Explore Evidence TypesFast-track eligibility, patent extension potential assessed.
The main point is that mapping of growing pathways names the shifting possibilities with the low-tonedest and the highest price with preliminary psychoanalysis.
View Regulatory PathsCompetitor programs, recent grants, partnership activity monitored.
A good solution is that veridical-time challenger in intelligence shows White Space and validates the market potential for every opportunity.
Learn About Competition